Italia markets close in 5 hours 57 minutes

bluebird bio, Inc. (0HOH.L)

LSE - LSE Prezzo differito. Valuta in USD.
Aggiungi a watchlist
181,25+177,89 (+5.294,34%)
Al 03:47PM BST. Mercato aperto.
Schermo intero
Chiusura precedente3,36
Aperto3,39
Denaro0,00 x 0
Lettera0,00 x 0
Min-Max giorno3,31 - 3,39
Intervallo di 52 settimane3,31 - 3,39
Volume3
Media VolumeN/D
Capitalizzazione10,064B
Beta (5 anni mensile)1,68
Rapporto PE (ttm)N/D
EPS (ttm)-10,43
Prossima data utili08 ago 2022 - 12 ago 2022
Rendimento e dividendo (forward)N/D (N/D)
Data ex dividendoN/D
Stima target 1AN/D
  • GlobeNewswire

    Adaptimmune Announces Appointment of Cintia Piccina as Chief Commercial Officer

    PHILADELPHIA and OXFORDSHIRE, United Kingdom, Jan. 26, 2022 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, today announces the appointment of Cintia Piccina as Chief Commercial Officer effective January 31, 2022. “I am delighted to welcome Cintia to our leadership team. She brings extensive commercial experience, including in cell and gene therapy, that will be key as we prepare to submit our first BLA for afami-cel this year, and buil